Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04698590 · ClinicalTrials.gov registry record · NA

Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism

A NA study of Keratoconus and Pellucid Marginal Corneal Degeneration, sponsored by Cornea and Laser Eye Institute.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04698590 is a NA study of Keratoconus and Pellucid Marginal Corneal Degeneration that is active but no longer recruiting, run by Cornea and Laser Eye Institute. The registered enrollment target is 100 participants, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04698590, a NA study of Keratoconus and Pellucid Marginal Corneal Degeneration, is active but no longer recruiting, sponsored by Cornea and Laser Eye Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Aberrations are the spreading of light from a point focus. Aberrations of the eyes can be objectively evaluated with a wavefront aberrometer. Lower order aberrations such as defocus and astigmatism can be corrected with glasses and traditional/disposable soft contact lenses. Patients with ectatic corneal disease, such as keratoconus, or irregular astigmatism cause by surgery, trauma or disease, experience vision that is unlikely to be adequately corrected with glasses or disposable soft contact lenses due to higher order aberrations (HOA). HOA's cause halos, flare, glare, starbursts, doubling, smearing or ghosting of vision. Specialty contact lenses, such as scleral lenses, can be used to mask the irregularity of the cornea, reducing HOA's and improving vision. In many patients the resultant vision, though improved, still has some level of residual HOA's affecting the quality of vision. Custom scleral lenses with customized wavefront guided optics can be used to reduce residual HOA's and improve vision further. These lenses have been referred to as higher order aberration correcting scleral lenses or HOA correcting sclerals and wavefront guided scleral lenses or WFG sclerals.

Interventions

  • DEVICE Wavefront Guided Scleral Lenses
  • DEVICE Traditional Scleral Lenses

Study Locations (1)

New Jersey

  • Cornea and Laser Eye Institue - Hersh Vision Group - Teaneck

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-01-15
Est. Completion 2025-12-31
Phase NA

Sponsor

Cornea and Laser Eye Institute

2 total trials

What the Registry Record Tells You About NCT04698590

The ClinicalTrials.gov registry entry for NCT04698590 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower). The listed sponsor is Cornea and Laser Eye Institute, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Keratoconus appearing as the primary indexed condition, and to 2 interventions - of which Wavefront Guided Scleral Lenses is the first listed.

NCT04698590 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04698590 about?

NCT04698590 is a clinical study titled "Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism". Aberrations are the spreading of light from a point focus. Aberrations of the eyes can be objectively evaluated with a wavefront aberrometer. Lower order aberrations such as defocus and astigmatism can be corrected with glasses and traditional/disposable soft contact lenses. Patients with ectatic co...

What is the current status of trial NCT04698590?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-15. Estimated completion is 2025-12-31.

What conditions does trial NCT04698590 study?

This clinical trial studies the following conditions: Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Ectasia, Irregular Astigmatism, Aberration, Corneal Wavefront.

What interventions are being tested in trial NCT04698590?

The interventions under investigation include: Wavefront Guided Scleral Lenses (DEVICE), Traditional Scleral Lenses (DEVICE).

Who is sponsoring clinical trial NCT04698590?

This trial is sponsored by Cornea and Laser Eye Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04698590 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Keratoconus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.